192 related articles for article (PubMed ID: 7912678)
1. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.
Pinczowski D; Ekbom A; Baron J; Yuen J; Adami HO
Gastroenterology; 1994 Jul; 107(1):117-20. PubMed ID: 7912678
[TBL] [Abstract][Full Text] [Related]
2. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Rutter M; Saunders B; Wilkinson K; Rumbles S; Schofield G; Kamm M; Williams C; Price A; Talbot I; Forbes A
Gastroenterology; 2004 Feb; 126(2):451-9. PubMed ID: 14762782
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire.
Moody GA; Jayanthi V; Probert CS; Mac Kay H; Mayberry JF
Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1179-83. PubMed ID: 8980937
[TBL] [Abstract][Full Text] [Related]
4. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
[TBL] [Abstract][Full Text] [Related]
5. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.
Kornfeld D; Ekbom A; Ihre T
Gut; 1997 Oct; 41(4):522-5. PubMed ID: 9391253
[TBL] [Abstract][Full Text] [Related]
6. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
[TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis and colorectal cancer. A population-based study.
Ekbom A; Helmick C; Zack M; Adami HO
N Engl J Med; 1990 Nov; 323(18):1228-33. PubMed ID: 2215606
[TBL] [Abstract][Full Text] [Related]
8. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden.
Stewénius J; Adnerhill I; Anderson H; Ekelund GR; Florén CH; Fork FT; Janzon L; Lindström C; Ogren M
Int J Colorectal Dis; 1995; 10(2):117-22. PubMed ID: 7636371
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.
Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H
Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer risk and mortality in patients with ulcerative colitis.
Langholz E; Munkholm P; Davidsen M; Binder V
Gastroenterology; 1992 Nov; 103(5):1444-51. PubMed ID: 1358741
[TBL] [Abstract][Full Text] [Related]
12. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study.
Nuako KW; Ahlquist DA; Mahoney DW; Schaid DJ; Siems DM; Lindor NM
Gastroenterology; 1998 Nov; 115(5):1079-83. PubMed ID: 9797361
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer prevention in ulcerative colitis: a case-control study.
Eaden J; Abrams K; Ekbom A; Jackson E; Mayberry J
Aliment Pharmacol Ther; 2000 Feb; 14(2):145-53. PubMed ID: 10651654
[TBL] [Abstract][Full Text] [Related]
15. Cancer in patients with ulcerative colitis.
Mellemkjaer L; Olsen JH; Frisch M; Johansen C; Gridley G; McLaughlin JK
Int J Cancer; 1995 Jan; 60(3):330-3. PubMed ID: 7829239
[TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis.
Loftus EV; Sandborn WJ; Tremaine WJ; Mahoney DW; Zinsmeister AR; Offord KP; Melton LJ
Gastroenterology; 1996 Feb; 110(2):432-40. PubMed ID: 8566590
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
Gyde SN; Prior P; Allan RN; Stevens A; Jewell DP; Truelove SC; Lofberg R; Brostrom O; Hellers G
Gut; 1988 Feb; 29(2):206-17. PubMed ID: 3345932
[TBL] [Abstract][Full Text] [Related]
20. Does patient knowledge affect the colorectal cancer risk in ulcerative colitis?
Eaden JA; Abrams K; Mayberry JF
Postgrad Med J; 2002 Oct; 78(924):615-8. PubMed ID: 12415086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
